Checkpoint Therapeutics ( NASDAQ: CKPT ) said it is looking to raise gross proceeds of $12M through a direct offering. The company has entered into definitive agreement with a single healthcare-dedicated institutional investor for the issuance and sale of an aggregate of 5.85M shares at $2.
05 apiece. The company will also issue and sell unregistered warrants to purchase up to 5.85M, which will have an exercise price of $2.
05 apiece. Shares in the company were up 2.4% in premarket trade.
More on Checkpoint Therapeutics Seeking Alpha’s Quant Rating on Checkpoint Therapeutics Historical earnings data for Checkpoint Therapeutics Financial information for Checkpoint Therapeutics.
